SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: Data from the CATIE study

SCHIZOPHRENIA RESEARCH

ELSEVIER SCIENCE BV

1. NIMH NIH HHS [K01 MH093731, K01 MH093731-01] Funding Source: Medline